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        Aff  erent lymphatic vessels transport interstitial 
fl  uid and cells from tissues before terminating in 
draining lymph nodes. DCs and T cells are the 
major cellular components of aff  erent lymph ( 1  –  3  ), 
but very few DCs enter eff  erent lymph (  3, 4  ). 
Infl  ammatory stimuli increase the rate of aff  erent 
lymphatic DC output by approximately an or-
der of magnitude (  5  ). However, infl  ammatory 
stimuli are not required for DC and T cell entry 
into aff  erent lymphatics, because the recovery of 
these cells from lymph in the steady state is still 
substantial (5). Indeed, the projected aff  erent 
lymphatic DC output is high enough to fully 
supply all lymph node DCs, even considering a 
short DC lifespan (  4  ). Thus, from these early ob-
servations, it seemed quite plausible that lymph 
was the major source of lymph node DCs in 
general. Reinforcing this possibility were other 
early studies revealing that DCs purifi  ed from 
the spleen can, upon adoptive transfer, immi-
grate to lymph nodes through lymphatic vessels 
but not through the bloodstream (  6  ). Further-
more, revelations that the steady-state turnover 
of pulmonary DCs is very rapid fi  t well with the 
interpretation that this fast turnover was linked 
to a high rate of DC entry into aff  erent lymphat-
ics (  7  ). Functionally, DCs that migrate through 
aff  erent lymph to lymph nodes in the steady state 
transport parenchymal antigens from various 
organs (  8  –  10  ), and such transport may facilitate 
the initiation of peripheral immune tolerance (  11  ), 
possibly working in concert with other mech-
anisms that give rise to tolerance within lymph 
nodes (  12  ). 
  More recently, our understanding of DC 
homeostasis in lymph nodes has evolved to 
include not only lymph-migrating DCs but also 
a role for DCs that enter from blood vessels, 
the specialized high endothelial venules, to 
maintain specifi  c DC subsets, notably plasma-
cytoid DCs (  13, 14  ) and mouse CD8      +   DCs 
(  15, 16  ). Accordingly, a recent review of DC 
biology suggested that half of the DCs within 
lymph nodes enter from the bloodstream, in-
cluding the full complement of these special-
ized subsets, but the other half of DCs were 
still believed to arise from lymph-migrating tis-
sue DCs (for review see reference   17  ). This 
conclusion was based in part on the notion that 
it is possible to readily identify which DCs 
traveled to lymph nodes through afferent 
lymph based on combinations of various mark-
ers, such as higher expression of MHC II in the 
steady state (  18, 19  ). However, the relationship 
between DCs bearing such markers and their 
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many organs and that DCs in some tissues, such as the lung, turnover rapidly in the steady 
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nodes only after introduction of an infl  ammatory stimulus. 
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  When we analyzed blood monocytes in LysM-Cre   ×   
Rosa26-stop  fl  ox  EGFP mice in the steady state, the two subsets of 
circulating CD115  hi   blood monocytes (  32  –  34  ) diff  ered in the 
percentage that was EGFP  +  . Ly-6C  hi   monocytes (sometimes 
called Gr-1  hi   monocytes) were on average 55% EGFP  +  , whereas 
the Ly-6C  lo   monocyte subset (sometimes called Gr-1  lo   mono-
cytes) averaged 75% EGFP  +   (  Fig. 1 A  ).   Since their discovery in 
mice, these two subsets have not been further subdivided, and 
accordingly, we found no obvious diff  erences in cell-surface 
markers between EGFP        and EGFP  +   monocyte subpopula-
tions. Furthermore, transfer of EGFP        monocytes into congenic 
recipient mice revealed that, 1 d later, many of the transferred 
EGFP        monocytes had become EGFP  +   (unpublished data), in-
dicating that EGFP        monocytes do not maintain a distinct pop-
ulation from EGFP  +   monocytes. Instead, the failure of EGFP 
to be uniformly expressed by a given monocyte subset in blood 
is more likely caused by the stochastic failure of strong lysozyme 
promoter usage or Cre-mediated excision of the stop cassette in 
the reporter construct. 
  In blood, CD115  lo   cells are granulocytes, mostly high-
scatter neutrophils, and 93% of these cells were EGFP  +   on 
average, consistent with the expectation that the lysozyme 
promoter is most strongly transcribed in these cells (  Fig. 1 A  ). 
Because of a low level of utilization of the lysozyme pro-
moter by hematopoietic stem cells (  31  ), populations other 
than neutrophils and monocyte-derived cells, such as lym-
phocytes, were EGFP  +   at a low frequency, but this frequency 
(6% EGFP  +   on average;   Fig. 1 A  ) was substantially less than 
that of neutrophils or monocytes. As expected, control WT 
naive mice had no EGFP expression, whereas mice that have 
EGFP knocked into the Rosa26 locus for constitutive ex-
pression (  35  ) showed that   >  98% of monocytes were EGFP  +  , 
thus indicating that the Rosa26 promoter is constitutively 
active in these cells (  Fig. 1 A  ). 
  In the bone marrow, monocytes are mainly Ly-6C  hi   mono-
cytes (  36  ), and these monocytes were EGFP  +   at a frequency 
similar to their blood counterparts, averaging 50% EGFP  +   (  Fig. 
1 B  ). In contrast, the recently described macrophage DC pro-
genitors (MDPs) (  24  ), identifi  ed as CD115  +   lineage        cells (  37  ), 
were EGFP  +   to a lower frequency (14% on average;   Fig. 1 B  ). 
  Although not all monocytes were EGFP  +  , we reasoned 
that populations of DC subsets derived from monocytes 
should express EGFP at a percentage at least equal to the per-
centage of monocytes that scored positive. If the lysozyme 
promoter remained or became active during the diff  erentia-
tion of DCs after the monocyte stage, the percentage of DCs 
positive for EGFP might exceed that of monocytes. How-
ever, DCs positive for EGFP at a percentage suffi   ciently high 
to meet the criterion for potentially being derived from 
monocytes would not prove that they originated from mono-
cytes. Nonetheless, as long as the Rosa26 promoter upstream 
of the EGFP reporter remained active, DC populations ex-
pressing a much lower fraction of EGFP than blood mono-
cytes certainly could not be derived primarily from monocytes, 
and most importantly, EGFP        DC populations could not be 
descendents of EGFP  +   DCs or monocytes. 
presumed precursors derived from upstream tissue has not 
been established. 
  Our past studies on the role of monocytes as a potential 
source of lymph-traffi   cking DCs (  20  –  22  ) fueled our interest 
in the relationship between nonlymphoid organ DCs and 
lymph node DCs. Several recent studies have concluded that 
spleen DCs do not arise from monocytes using adoptive 
transfer approaches (  23  –  26  ). In addition, a study in parabiotic 
mice suggested that monocytes are also not precursors for 
lymph node DCs, because blood monocytes and lymph node 
DCs exchanged between parabionts to diff  ering extents (  27  ). 
Strikingly, one of these studies indicated that, in strong con-
trast to spleen DCs, monocytes are precursors of peripheral 
nonlymphoid organ DCs (  25  ), implying for the fi  rst time that 
DCs in lymphoid organs may have a distinct origin from DCs 
in nonlymphoid organs. However, little lineage analysis has 
been conducted in lymph nodes, which in contrast to the 
spleen, are positioned to serve as a nexus wherein lymphoid 
organ  –  resident DCs and nonlymphoid organ DCs would 
converge, presumably in equal proportions (  17  ), to interact 
with lymphocytes and drive immune responses. 
  Indications that nonlymphoid organ DCs may arise from 
monocytes (  22, 25, 28  ), in contrast to other DCs, suggested 
to us an approach to analyze the proportion of lymph node 
DCs that might arise from DCs originating in upstream tis-
sues. In this study, we used a popular reporter mouse line that 
uses the lysozyme promoter, active in many monocytes, to 
drive   Cre   recombinase (  29  ) that subsequently removes a stop 
cassette upstream of enhanced GFP (EGFP) (  30  ). Studies in 
this model fi  t well with the evidence that nonlymphoid organ 
and spleen DCs may be unrelated in origin and, most impor-
tantly, reveal that, against expectations and prevailing models 
in the fi  eld, only a minority of lymph node DCs in the steady 
state arises from DCs residing in upstream nonlymphoid or-
gans. Instead, DCs that migrate through lymphatics from up-
stream tissues contribute substantially to the pool of lymph 
node DCs, mainly during infl  ammatory states. 
    RESULTS   
  Illustration of the utility of lysozyme M (LysM)  –  Cre   ×   
Rosa26-stop  fl  ox  EGFP mice to assess DC relationships 
with monocytes or other DC populations 
  LysM is expressed by neutrophils and macrophages. Accord-
ingly, LysM-Cre mice (  29, 31  ) have been widely used to gen-
erate cell type –  selective deletions of fl  oxed genes or expression 
of fl  oxed reporter markers, especially Rosa26 promoter-
driven reporter genes. In these mice,   Cre   activity removes a 
stop cassette upstream of the fl  oxed reporter in neutrophils 
and monocyte-derived macrophages. Neutrophils are not 
considered candidates for DC precursors, but monocytes may 
be precursors for at least some DC populations (  20  –  22, 25  ). If 
only some DCs are derived from monocytes, and if the lyso-
zyme promoter has low activity in other DC precursors, then 
the LysM-Cre reporter mice would be a useful tool to trace 
relationships between monocytes and DCs and possibly be-
tween diff  erent DC populations in vivo. JEM VOL. 205, November 24, 2008 
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we separately evaluated EGFP expression in these subsets, 
labeled as populations 1 –  3 ( Fig. 1 C ). CD11c  int  CD11b       B220  +   
cells were plasmacytoid DCs (  Fig. 1 C  , population 4). Other 
CD11c  int   or CD11c        populations that expressed high CD11b 
were likely splenic monocytes and macrophages (  37  ), and 
these could be divided in three populations (  Fig. 1 C  , la-
beled populations 5  –  7). In our analyses, we used monocytes 
as a reference population to normalize the data and draw a 
direct comparison to monocytes. In every mouse analyzed, 
we calculated the percentage of EGFP expressed in a given 
  Thus, we next analyzed DC subsets in the spleens of 
LysM-Cre   ×   Rosa26-stop  fl  ox  EGFP mice to determine if their 
propensity to express EGFP may diff  er from that of mono-
cytes, as might be expected from previous work (  23  –  26  ). 
When total CD11c  +   cells were considered, EGFP  +   frequency 
more closely matched that of MDPs than monocytes (  Fig. 
1 C  ). To assess spleen DCs more carefully, we analyzed various 
DC subsets by further fl  ow cytometric staining and gating. 
Conventional DCs in the spleen are CD11c  hi   cells that diff  er-
entially express CD8     and CD11b, and based on these gates, 
    Figure 1.         EGFP reporter expression in LysM-Cre   ×   Rosa26-stop  fl  ox  EGFP mice by blood monocytes and spleen macrophages or DCs.   (A)  EGFP 
frequency in blood populations was analyzed. CD115 and Gr-1/Ly-6C stainings identifi  ed blood monocyte subsets in wild-type C57BL/6 mice, Rosa26-
EGFP knock-in mice, or LysM-Cre   ×   Rosa26-stop  fl  ox  EGFP mice. The percentage of each subset that expressed EGFP was analyzed. High side scatter (SSC) 
and lower levels of CD115 expression were used to discern neutrophils. Low SSC CD115        cells, which are mostly lymphocytes, were evaluated to measure 
the extent of promiscuous usage of the lysozyme promoter (reference   31  ). (right) Plot shows the percentage of EGFP of various blood populations in all 
mice enrolled in this study (  n   = 60). (B) The percentage of EGFP  +   cells in CD115  hi   bone marrow cells in LysM-Cre   ×   Rosa26-stop  fl  ox  EGFP mice was ana-
lyzed and plotted. A panel of lineage markers was fi  rst used to narrow down bone marrow cells that might be monocytes or MDPs. Bone marrow mono-
cytes were CD115  hi   cells that coexpressed the lineage markers Gr-1 and/or CD11b (lineage stain 2), whereas MDPs were lineage        CD115 hi   cells  (reference 
  37  ). Data represent the mean   ±   SEM. (C) Stainings for CD11c, CD11b, CD8    , and B220 defi  ned conventional DC subsets and other populations in steady-
state spleens of LysM-Cre   ×   Rosa26-stop  fl  ox  EGFP mice or Rosa26-GFP knock-in mice. Conventional DCs correspond to populations 1 (CD8    +   DCs),  3 
(CD8          DCs), and 4 (plasmacytoid DCs). Macrophages comprise gates 6 and 7, and gate 5 includes monocytes (reference   37  ). The percentage of EGFP in 
these and other designated populations was normalized to the percentage of EGFP  +   Ly-6C hi   monocytes in the same mouse. In the graphs, all mice stud-
ied are compiled, and each data point corresponds to one mouse. Two to three mice per group were handled per experiment. Horizontal bars on scatter 
plots represent means. In B, two experiments were performed with three mice in each.     2842 ANATOMIC ORIGIN OF LYMPH NODE DENDRITIC CELLS   | Jakubzick et al. 
EGFP  +   in LysM-Cre   ×   Rosa26-stop  fl  ox  EGFP mice. CD11c  hi   
cells with lower levels of MHC II could be separated into 
two populations based on diff  erential surface expression of 
CD11b. One of these populations, representing from 4 to 
10% of MHC II  +   CD11c  +   cells and expressing low levels of 
CD11b (  Fig. 2 C  , gate 1/LP1), was mainly EGFP        and stood 
out as the only potential DC population in any of the non-
lymphoid organs examined that expressed EGFP at percent-
ages as low as those observed for spleen DCs. However, this 
population was also CD8      +   (  Fig. 2 C  ), resembling a subset of 
CD11c  hi  CD11b  lo  CD8      +   DCs in nearby Peyer  ’  s patches (  41  ) 
and CD8      +   lymph node DCs in general. Indeed, this popu-
lation may not be part of the LP proper but instead may be a 
contaminant from Peyer  ’  s patches, as we noticed that the 
population became progressively reduced in frequency (down 
to 4% of recovered DCs) as our skills in the dissection of the 
Peyer  ’  s patches away from the LP improved. Another popu-
lation (  Fig. 2 C  , gate 2/LP2) expressed intermediate levels of 
EGFP that did not reach the frequency of EGFP  +   cells ob-
served in monocytes but that maintained a frequency higher 
than spleen DCs. These cells (  Fig. 2 C  , gate 2/LP2) are likely 
the DCs that populate the villi of the intestine and upper LP 
layers, because in some mice, we recovered DCs from villous 
tips that were removed while stripping the intestinal epithe-
lium (  Fig. 2 C  , Villi DC), and the LP DCs recovered from 
these villi appeared identical in phenotype (not depicted) and 
EGFP  +   frequency to LP2 (  Fig. 2 C  ). 
  Considering data from all of these organs together, we 
conclude that most nonlymphoid organ DCs or their precur-
sors use the lysozyme promoter in the steady state. This feature 
distinguishes them from spleen DCs and is consistent with, but 
does not prove, that the origins of nonlymphoid organ DCs 
may be distinct from spleen DCs, as previously proposed (  25  ). 
  Nonlymphoid organ  –  derived DCs are scarce in lymph nodes 
  Because it is thought that lymph nodes receive substantial 
seeding by DCs that emigrate from upstream nonlymphoid 
organs through the aff  erent lymphatics (see Introduction), we 
expected to fi  nd that lymph node DCs, and discrete subpop-
ulations of DCs in particular, would express a higher fre-
quency of EGFP than observed in spleen DCs. However, the 
frequency of EGFP  +   cells within lymph node DC subpopula-
tions was much like that of spleen DCs, with the exception 
of skin-draining lymph nodes (  Fig. 3, A  –  C  ).   This could not 
be attributed to loss of reporter expression through failure to 
use the Rosa26 promoter, because all lymph node cells and 
all CD11c  int   and CD11c  hi   cells that would be candidate DCs 
were EGFP  +   in Rosa26-EGFP knock-in mice (  Fig. 3 D  ). 
  None of the classical DC populations in the mesenteric 
or lung-draining lymph nodes mirrored the percentage of 
EGFP  +   DC populations of the upstream organs (  Fig. 3 A  , 
gates 1  –  3; and   Fig. 3 B  , gates 1  –  4; compare with   Fig. 2, 
B and C  ). As in the spleen, the frequency of EGFP  +   cells 
was elevated in CD11b  hi  CD11c  int   and CD11b  hi  CD11c        
lymph node populations, but these are not typically con-
sidered classical DC populations (  Fig. 3 A  , gates 4 and 5; 
spleen DC or macrophage population and divided this value 
by the percentage of Ly-6C  hi   monocytes that were EGFP  +   
in the same mouse, because DCs might arise from Ly-6C  hi   
monocytes in some tissues (  20  –  22, 25      ). If the percentage of 
a given DC subset that was EGFP  +   was similar to Ly-6C  hi   
monocytes, then the product of this division would produce 
a value of 1. Ratios substantially   <  1 would indicate popula-
tions that could not have received a majority of precursor 
input from monocytes or any other EGFP  +   population. In the 
spleen, all DC subsets (  Fig. 1 C  , gated populations 1  –  4) (  37  ) 
exhibited a low level of EGFP expression and, fi  tting with 
previous conclusions (  23  –  26  ), did not meet the criterion for a 
potentially close relationship with monocytes. Failure to meet 
this criterion was not caused by inactivity at the Rosa26 pro-
moter, because CD11c  hi   and CD11c  int   cells were uniformly 
EGFP  +   in control Rosa26-EGFP knock-in mice (  Fig. 1 C  ). 
In contrast to DCs, monocytes and macrophages in the spleen 
(gated populations 5  –  7) (  37  ) met or exceeded the minimal 
criterion for possible derivation from monocytes (  Fig. 1 C  ), 
serving as a positive control for the approach taken. 
  Reporter expression by nonlymphoid organ DCs is distinct 
from spleen DCs in the steady state 
  Next, we examined peripheral organ DCs in skin, lung, and 
small intestine in the steady state. Skin DCs were separated 
into epidermal DCs (Langerhans cells;   Fig. 2 A  ) and dermal 
DCs that, as a whole, are CD11c  +   and MHC II  +   (  Fig. 2 A  , 
Dermal 1) (  38  ).   These tissue DC populations showed a much 
higher frequency of EGFP  +   cells than that observed for spleen 
DCs, and overall, the frequency of EGFP  +   skin DCs resem-
bled the frequency seen in Ly-6C  hi   blood monocytes (  Fig. 
2 A  ). As noted previously (  38  ), CD11b  hi  CD11c        cells in the 
dermis could be separated into MHC II  +   and MHC II        pop-
ulations (  Fig. 2 A  , Dermal 2 and 3, respectively). These cells 
likely include macrophages (  38  ), with considerable heteroge-
neity in CD11b  hi   MHC II  lo   cells. Overall, these populations 
also showed a frequency of EGFP expression that resembled 
Ly-6C  hi   monocytes (  Fig. 2 A  ). 
  Pulmonary DCs are identifi  ed as CD11c  +   cells with low 
autofl  uorescence, whereas CD11c  +   cells with high autofl  uo-
rescence are macrophages (  22  ). Two subsets of pulmonary 
DCs exist, displaying diff  erential expression of CD11b and 
CD103: CD103  +  CD11b  lo   and CD103       CD11b  hi   DCs (  22, 
39, 40  ). Both DC subsets, whether recovered from the lung 
interstitium or bronchoalveolar lavage (BAL), were EGFP  +   
to a similar extent as Ly-6C  hi   blood monocytes (  Fig. 2 B  ). 
Macrophages in the BAL were nearly 100% EGFP  +   (  Fig. 2 B  ), 
yielding a mean ratio of     2. Thus, as in the skin, DCs in the 
lung displayed considerable expression of EGFP, in contrast 
to spleen DCs and consistent with previous suggestions that 
blood monocytes may serve as a major precursor source for 
these cells (  22, 25, 28  ). 
  In the small intestine, we analyzed DCs and/or macro-
phages in the lamina propria (LP). Two thirds of MHC II  +   
cells expressed high levels of CD11b and intermediate levels 
of CD11c (  Fig. 2 C  , gate 3/LP3). Most of these cells were JEM VOL. 205, November 24, 2008 
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organ EGFP  +   DCs and draining lymph node EGFP  +   DCs, 
even in the lung, where it has been shown that DC turn-
over is especially rapid (Fig. S1, available at http://www.jem
.org/cgi/content/full/jem.20081430/DC1). 
  Like the other lymph nodes, most skin-draining lymph 
node DCs were EGFP       , but certain populations of DCs 
within skin-draining lymph nodes, especially those that were 
langerin  +  , were EGFP  +  . Expression of langerin, found on all 
epidermal DCs and a small fraction of dermal DCs (  21, 38  ), 
is considered a long-lasting marker of DCs that survey the skin 
and enter skin-draining lymph nodes through lymphatics (  42  ). 
  Fig. 3, B and C  , gates 5 and 6). Instead, these gates have 
been suggested to mainly include macrophages and newly 
recruited monocytes (  37  ). The lack of EGFP expression in 
most lymph node DCs was not likely caused by dilution of 
EGFP during the proliferation of EGFP  +   DCs that migrated 
in from the upstream organs, because if the proliferation of 
DCs accounted for loss of EGFP, we would expect to fi  nd 
DCs with a range of reduced EGFP intensities in the drain-
ing lymph node representing DCs that had divided diff  erent 
numbers of times since leaving the upstream organ; instead, 
EGFP intensity was not diff  erent between nonlymphoid 
    Figure 2.         EGFP reporter expression in LysM-Cre   ×   Rosa26-stop  fl  ox  EGFP mice by DCs and macrophages from skin, lung, and small intestine.  
(A) Single-cell suspensions were prepared from the epidermis and dermis. Epidermal DCs were CD11c  +   langerin +  , and dermal DCs were gated as CD11c  +  
CD11b  hi   MHC II  hi   (dermal 1), CD11c        CD11b hi   MHC  II hi   (dermal 2), or CD11c        CD11b hi   MHC  II lo   (dermal 3). The percentage of EGFP  +   cells in these popula-
tions was normalized to the percentage of EGFP  +   Ly-6C hi   monocytes in the same mouse. (B) The percentage of EGFP in the BAL and lung of the two DC 
subsets (CD103      CD11b hi   and  CD103 + CD11b lo  ) and macrophages was normalized to the percentage of EGFP  +   Ly-6C hi   monocytes in the same mouse. 
(C) Gated live cells derived from the small intestine LP (or LP associated with the villous tips during removal of the epithelium) were stained and analyzed to 
reveal populations expressing CD11c, CD11b, CD8    , and MHC II. The LP contained lymphocytes and three populations that resembled DCs and/or macro-
phages, including CD11c  hi   MHC  II int   cells that differed with respect to CD11b expression (LP1 and LP2). Population LP2 was also associated with villous tips 
processed along with the intestinal epithelium (Villi DC). The third population was CD11c  int   MHC  II hi   CD11b hi   (LP 3). The percentage of these LP populations 
that were EGFP  +   was normalized to the percentage of EGFP  +   Ly-6C hi   monocytes in the same mouse. In each graph, all mice studied are compiled, and 
each data point corresponds to one mouse. Two to three mice per group were handled per experiment. Horizontal bars represent means.   2844 ANATOMIC ORIGIN OF LYMPH NODE DENDRITIC CELLS   | Jakubzick et al. 
other lymph nodes examined, as they showed evidence of 
containing tissue-derived DCs, with up to 20% of the total 
lymph node DCs (    10% langerin  +   cells plus half of the 
DCs in gate 2 equals     20%;   Fig. 3 C  ) possibly arriving from 
skin lymphatics. 
  DCs highly enriched in MHC II were observed in skin- 
and lung-draining lymph nodes, present on average in 17 and 
9% of total CD11c  +   cells, respectively. MHC II  hi   DCs were 
not readily identifi  ed in mesenteric lymph nodes or the spleen 
(  Fig. 3 E  ), although in other studies MHC II  hi   cells were 
found in the spleen (  43  ), indicating that even under specifi  c 
Langerin  +   cells in resting LysM-Cre   ×   Rosa26-stop  fl  ox  EGFP 
mice represented, on average, 10% of all CD11c  +   cells in 
skin-draining lymph nodes and fell in gates 1 and 4 according 
to the intensity of CD11c, CD11b, and CD8     staining 
used to divide the subsets (  Fig. 3 C  ). These langerin  +   lymph 
node DCs and CD11b  hi   CD11c  hi   CD8            langerin        DCs 
(  Fig. 3 C  , gate 2) expressed a percentage of EGFP that was 
elevated above the fraction seen in background populations 
such as lymphocytes, but the EGFP levels were somewhat 
lower than any of the upstream populations of skin DCs (  Fig. 
2 A  ). Collectively, skin-draining lymph nodes contrasted with 
    Figure 3.         EGFP reporter expression in LysM-Cre   ×   Rosa26-stop  fl  ox  EGFP mice by DCs within lymph nodes that drain intestine, lung, or skin.  
Stainings for CD11c, CD11b, B220, and CD8     were used to delineate various DC subsets within lymph nodes. Conventional CD11c  hi   cells comprised popula-
tions in gates 1 and 2 for all lymph nodes (A  –  C), and also gate 3 for lung-draining lymph nodes (B). Plasmacytoid DCs were in gate 3 (A and C) or gate 4 
(B). In skin-draining lymph nodes, gate 4 was considered a DC population because many of the langerin  +   cells were found within it (C). The lower fl  ow 
cytometry plot in C is an overlay of langerin  +   cells (black) over all live cells (gray). Monocytes and macrophages were within populations 4 and 5 (A) or 5 
and 6 (B and C). The percentage of EGFP within these gated lymph node populations was normalized to the percentage of EGFP  +   Ly-6C hi   monocytes in the 
same mouse. In pooled skin-draining lymph nodes, the mean percentage of each DC population relative to the DC gates overall is shown beneath the bar 
graph. (D) Flow cytometry of a representative lymph node (a skin-draining lymph node) from Rosa26-GFP knock-in mice. Live cells were gated on and 
plotted to show CD11c versus EGFP. (E) Various lymph nodes and spleens from LysM-Cre   ×   Rosa26-stop  fl  ox  EGFP mice were stained with anti  –  MHC II mAb 
to identify CD11c  +   cells with very high MHC II expression. Plots of these stains are shown on the left, with gated populations of MHC II  hi   cells (oval gates) 
within overall CD11c  +   cells (rectangular gates). The mean frequencies of this population in skin- and lung-draining lymph nodes are shown on the top 
right and are also indicated adjacent to the gate within the dot plots. Data represent the mean   ±   SEM. The bottom right plot shows the normalized 
frequency of EGFP  +   cells in these gated MHC II  hi   DCs. (F) Analysis of EGFP frequency in MHC II  hi   CD11c +   lymph node cells that were langerin  +   or  langerin     . 
In each graph, all mice studied are compiled, and each data point corresponds to one mouse. Two to three mice per group were handled per experiment. 
In E, two experiments were performed with three mice in each. Horizontal bars represent means.     JEM VOL. 205, November 24, 2008 
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(compare   Fig. 4 A   with   Fig. 2 A  ), but TRITC        DCs re-
mained mainly EGFP        (  Fig. 4 A  ). Overall, CD11c  hi   TRITC  +   
cells in the lymph node phenotypically resembled and showed 
a similar EGFP frequency as the Dermal 1 population in   Fig. 
2 A  , and CD11c  int   TRITC  +   cells most closely matched the 
Dermal 3 population in   Fig. 2 A   (  Fig. 4 A  ). These data indi-
cate that migrating DCs retain expression of EGFP during 
mobilization to downstream lymph nodes and illustrate that 
the migrating DC population does not favor EGFP        DCs in 
LysM-Cre   ×   Rosa26-stop  fl  ox  EGFP mice. 
  We next examined the eff  ect of tissue infl  ammation on 
populations of DCs in lung-draining lymph nodes. As men-
tioned earlier, CD103 expression marks approximately half of 
the pulmonary DCs, and its expression persists after the DC 
migrates to the downstream, lung-draining lymph node (  40, 46  ). 
We therefore monitored expression of CD103 by CD8            
DCs in the lung-draining lymph node to determine the fre-
quency of this migrated population therein. CD103  +  CD8            
DCs fell within the gate of CD11c  hi   CD11b  lo   DCs (  Fig. 4 B  ). 
These CD103  +   DCs in the lymph node refl  ected a frequency 
of EGFP expression expected from analysis of upstream tissue 
CD103  +  CD11b  lo   DCs (  Fig. 2 B  ) but comprised a very small 
component within the gate (  <  10% gated, and 4% of lymph 
node DCs overall) when noninfl  amed lymph nodes from mice 
treated with PBS were examined (  Fig. 4 B  ). However, when 
we treated mice intranasally with LPS to greatly enhance DC 
migration (  5, 40, 47  ) and examined the lymph node 24 h later, 
CD103  +  CD8            DCs were the dominant population in the 
same gate (  Fig. 4 B  , top left dot plots), and quantifi  cation of 
their absolute (  Fig. 4 C  ) and relative (  Fig. 4 D  ) frequency con-
fi  rmed that CD103  +   DCs were now the majority (60%) of the 
gated CD11c  hi  CD11b  lo   DCs (  Fig. 4 D  ) and represented 25% of 
the lymph node DCs overall. LPS treatment led to an increase 
in the absolute number of all DC populations (  Fig. 4, B and C  ), 
but migratory populations such as the CD103  +   DCs were dis-
proportionally increased (  Fig. 4, C and D  ; and not depicted). 
CD103  +   DCs were EGFP  +   to a similar normalized frequency 
as their upstream tissue counterparts (  Fig. 4 E  ). LPS increased 
the proportion of all lymph node DC subsets that expressed 
EGFP (  Fig. 4 F  ), but because it also increased the frequency of 
EGFP  +   monocytes and tissue DCs, it scarcely altered the nor-
malized data. Taking these observations together, we conclude 
that infl  ammatory stimuli, such as LPS or mediators like TNF-     
and IL-1 induced during contact sensitization (  48, 49  ), are 
generally necessary to provoke substantial accumulation of up-
stream tissue-derived DCs within lymph nodes that enter by 
way of the aff  erent lymphatic vessels, and that, in contrast and 
against our expectations, in the steady state the lymph node 
contains few nonlymphoid organ  –  derived DCs. 
    DISCUSSION   
  Historically, several observations led to the development of the 
view that lymph node DCs arose substantially from lymph-
borne DCs that originated in upstream tissues. First, DCs in 
cannulated afferent lymph are relatively abundant and are 
clearly involved in transporting antigen. In contrast, committed 
pathogen-free conditions the phenotype of DCs in the steady 
state can vary between diff  erent mouse colonies. Because mi-
grating DCs have sometimes been defi  ned by being MHC II  hi   
to a level elevated over other DCs (  18, 19  ), we assessed 
the frequency of EGFP  +   cells within gated MHC II  hi   lymph 
node DCs. The frequency of EGFP  +   MHC II  hi   DCs was, 
like langerin  +   DCs, elevated in this gate relative to lymph 
node DCs overall. However, the percentage of MHC II  hi   
CD11c  +   cells that were EGFP  +   (  Fig. 3 E  ) fell short of that 
observed in monocytes and in upstream tissue DCs (compare 
  Fig. 3 E   with   Fig. 2 A  ), suggesting that many but not all of 
the MHC II  hi   DCs might arise from defi  ned, upstream tissue 
DC populations. As expected (  18  ), the MHC II  hi   DC gate 
was partially redundant with the langerin  +   gated DCs, be-
cause in our analysis 31   ±   2% of MHC II  hi   DCs were also 
langerin  +   (  Fig. 3 F  ). There was no diff  erence in the EGFP 
frequency in either langerin  +   or langerin        MHC II  hi   cells 
(  Fig. 3 F  ), suggesting that some of the MHC II  hi   DCs may 
be migratory dermal DCs that are langerin        and that over-
all EGFP  +   MHC II  hi   DCs were equivalent to the sum of 
langerin  +   cells in gates 1 and 4 and DCs in gate 2, as shown 
in   Fig. 3 C  . 
  Given that EGFP  +   DCs could not give rise to EGFP        
DCs, the failure to observe substantial EGFP expression in 
the vast majority of lymph node DC populations suggests that 
upstream organ DCs do not substantially populate lymph 
nodes in the steady state and certainly cannot account for as 
many as half of lymph node DCs (  17  ). Clearly, some subpop-
ulations of DCs accumulated in steady-state lymph nodes, 
most notably langerin  +   and MHC II  hi   DCs within skin-drain-
ing lymph nodes, but these subpopulations maintained a rela-
tively low overall frequency. 
  Contrasting with the steady state, DCs from upstream 
organs are populous in lymph nodes that drain sites 
of infl  ammation and immune sensitization 
  One caveat to the conclusion drawn from   Fig. 3   is the possi-
bility that EGFP        organ DCs preferentially migrate to drain-
ing lymph nodes over their EGFP  +   counterparts. To consider 
this possibility and to be certain that migratory DCs could be 
detected as EGFP  +   cells in lymph nodes if they were present, 
we experimentally induced large-scale DC migration by ap-
plying a fl  uorescent contact sensitizer to the skin, thereby us-
ing one of the most established DC migration assays (  3, 44  ). 
Tetramethylrhodoamine-5-(and-6)-isothiocyanate (TRITC) 
was mixed with dibutylphthalate and acetone and applied 
epicutaneously to trace DC migration (  15, 45  ). As previously 
reported (  45  ), the migrating population observed in lymph 
nodes 1 d after sensitization were mainly langerin        cells (not 
depicted), which are thought to arise from dermal langerin        
DCs (  45  ), such as the CD11b  hi   populations observed in   Fig. 
2 A  . In the draining lymph node, TRITC  +   DCs represented 
  >  30% of all lymph node DCs (  Fig. 4 A  ) and fell within gates 
2 and 4, as shown for skin-draining lymph nodes in   Fig. 3 C   
(compare   Fig. 3 C   with   Fig. 4 A  , middle).   TRITC  +   cells 
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  The model system used herein used LysM-Cre   ×   Rosa26-
stop  fl  ox  EGFP mice that   “  report  ”   expression of LysM in neu-
trophils, monocytes, and macrophages by irreversibly inducing 
EGFP expression. A much lower frequency of expression is 
observed in T and B cells, stemming from promiscuous acti-
vation of the LysM promoter in some hematopoietic stem 
cells (  31  ). Although macrophages continue to express lyso-
zyme as they mature (  31  ), this gene is not considered to be a 
marker for DCs and may be turned off   developmentally upon 
induction of DC diff  erentiation. The current study  ’  s compar-
ison between tissue DC populations and those in the lymph 
node was possible because many tissue DCs, but not most 
lymph node or spleen DCs, expressed EGFP downstream of 
lysozyme promoter usage. The discrepancy in the frequency 
of the EGFP reporter between splenic and nonlymphoid 
DC precursors are sparse in the circulation of humans (  4  ). 
Furthermore, when aff  erent lymphatics are severed, the lymph 
node becomes nearly void of DCs (  50  ) and antigen presenta-
tion is blocked (  51  ). Recently, the idea that specialized DC 
subsets  —  plasmacytoid and CD8      +   DCs  —  enter the lymph 
node from the bloodstream has been introduced, but this un-
derstanding has not modifi  ed the belief that many lymph node 
DCs arise from interstitial nonlymphoid organ DCs that mobi-
lize through lymphatics (  16, 17  ) and may even mature in the 
steady state as they migrate (  19  ). In this study, we present sur-
prising evidence that most steady-state DCs in lymph nodes 
that drain a variety of organs by and large do not originate from 
upstream tissue DCs. Instead, we fi  nd that it is only during in-
fl  ammation that tissue-derived DCs comprise a major fraction 
of lymph node DCs. 
    Figure 4.         EGFP reporter expression in LysM-Cre   ×   Rosa26-stop  fl  ox  EGFP mice by DCs that migrate into lymph nodes from upstream organs in 
response to infl  ammatory stimulation.   (A) TRITC was applied to skin epicutaneously in a contact-sensitizing solution, and TRITC  +   cells in the draining 
lymph nodes 18 h later were identifi  ed (left dot plot, gated area) and further analyzed. The fl  ow cytometry plot on the right shows an overlay of TRITC  +  
cells (black) over all live lymph node cells (gray) with respect to the expression of CD11c and CD11b. The percentage of EGFP  +   cells within TRITC  +   and 
TRITC        lymph node DCs was normalized to the percentage of EGFP  +   Ly-6C hi   monocytes in the same mouse. Graph shows individual mice per data point. 
TRITC        DCs refers to a gate on TRITC        CD11c +   DCs that excludes the CD11b  hi CD11c int   gate that is considered to contain mainly monocytes (reference   37  ). 
The TRITC        CD11c +   grouping includes all DCs and the putative monocyte gate, thereby containing all TRITC        CD11c +   and  CD11c int   cells in the lymph node. 
(B) PBS or LPS was delivered intranasally (I.N.). 24 h later, live cells from the lung-draining lymph nodes were gated to identify CD11c  hi   CD11b lo   cells,  and 
gated CD11c  hi   CD11b lo   cells were examined for CD103 or CD8     expression, revealing three subpopulations: CD103  +   CD8         (CD103 +  ) lung-derived DCs, 
CD8    +   DCs, and double-negative DCs. Shown is the number (C) or percentage (D) of the CD103  +   CD8         (CD103 +  ) DCs, CD8    +   DCs, and double-negative 
DCs within the CD11c  hi   CD11b lo   gated population (from the FACS dot plot, top left) from the lung-draining lymph nodes treated with LPS (black squares) 
or with PBS (gray circles) to maintain near steady-state conditions. (E) Graph shows the effect of LPS treatment, used to induce DC migration from 
the lung, on the expression of EGFP by various populations, normalized to Ly6C  hi   monocytes within the same mouse. BAL and lung were gated on 
CD11c  hi CD11b lo CD103 +   DCs  (CD103 +  ). Lung-draining lymph node was gated on CD11c  hi CD11b lo CD103 +   DCs  (CD103 + ),  CD11c hi CD11b lo CD103       DCs  (CD103     ), 
and plasmacytoid DCs. Horizontal bars represent means. (F) Percentage of blood monocyte subsets and lymph node DC populations that expressed EGFP 
with or without intranasal LPS administration (from mice in E). In each graph, all mice studied are compiled, and each data point corresponds to one 
mouse. Two to three mice per group were handled per experiment. Data represent the mean   ±   SEM.     JEM VOL. 205, November 24, 2008 
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EGFP frequency than monocytes, these villi/LP CD11b  hi   DCs 
were EGFP  +   to a greater extent than any DC subset in the 
mesenteric lymph node, supporting the conclusion that these 
DCs did not comprise a major fraction of DCs in the mesen-
teric lymph node but are present only to a minor degree. 
  A caveat to our approach might be that the EGFP        DCs 
within a tissue preferentially have the capacity to migrate to 
lymph nodes. However, this is quite unlikely for several rea-
sons. First, in all cases in which we can identify small popula-
tions of tissue-derived DCs, by gating on langerin  +   DCs in 
skin-draining lymph nodes or CD103  +  CD11b  lo   DCs in lung-
draining lymph nodes, we see a close refl  ection of the EGFP 
frequency observed in the corresponding upstream tissue DC 
population. Second, during infl  ammation, upstream tissue-
derived DCs are quite abundant in lymph nodes, and there is 
no bias toward EGFP        DCs. Thus, in all cases in which we 
analyze DCs confi  rmed to migrate from upstream organs to 
lymph nodes, we observe the expected frequency of EGFP. 
Finally, momentarily disregarding an approach based on anal-
ysis of EGFP frequency in LysM-Cre   ×   Rosa26-stop  fl  ox  EGFP 
mice, an examination of total numbers of CD11b  lo  CD103  +   
DCs in steady-state versus infl  amed lung-draining lymph 
nodes (  Fig. 4 B  , bottom graphs) leads to a similar conclusion 
as that drawn from data that depend on the premises made in 
studies of LysM-Cre   ×   Rosa26-stop  fl  ox  EGFP mice. 
  Although we conclude that the presence of nonlymphoid 
organ DCs is more minimal than expected in lymph nodes, 
this fi  nding does not necessarily dispel the possibility that there 
is a relatively high frequency of DCs traffi   cking through lymph 
constitutively. For example, the lifespan of lymph-migrating 
DCs, especially in the steady state, may be quite brief within 
downstream lymph nodes. All of the available evidence indeed 
suggests that DC turnover in general is very rapid in lymph 
nodes (  15, 27  ). Skin-resident dermal and epidermal DCs may 
in particular survive and persist in lymph nodes longer than 
other DC populations (  53, 54  ). Our fi  nding that these skin 
DC populations were the most enriched nonlymphoid organ  –
  derived DCs in all lymph node examined corresponds with 
the idea that lifespan may be the major regulator of the pres-
ence of migratory tissue DCs within the lymph node. 
  Even as ephemeral constituents within lymph nodes, 
migratory DCs could still play a major role in immunity in 
the steady state. However, their failure to accumulate in 
lymph nodes for substantial durations fi  ts best with a role 
in which they supply antigen, already processed or not, to 
other DCs within lymph nodes (  55, 56  ). Transfer of antigen 
from migratory DCs to other DCs may be at least as sub-
stantial, or more so, in the steady state as it has been pro-
posed to be during infection (  56  ). The appearance of parietal 
antigens in CD8      +   DCs (  10  ), a population of so-called 
lymph node  –  resident DCs that our data uphold do not de-
rive from upstream tissue DCs, suggests that even large frag-
ments of tissue antigens are not restricted within the lymph 
node to migratory DCs but are instead readily shared with 
other DCs. Alternatively, migratory DCs may often possess 
a phenotype distinct from that expected. CD11c  int  CD11b  hi   
organ DCs is consistent with the possibility that nonlymphoid 
organ DCs may derive from monocytes or some other lyso-
zyme-positive precursor, but that most lymph node or spleen 
DCs do not (  25  ). Both lymph node and spleen DCs more 
closely expressed the frequency of EGFP observed in bone 
marrow DC precursors called MDPs (  24, 37  ), which do 
not inevitably diff  erentiate into monocytes and may shut off   
EGFP as they diff  erentiate into alternative end-stage cells, in-
cluding DCs. Although complementing former adoptive 
transfer studies, (  23  –  25  ) our approach has the advantage of 
permitting examination of mice with no previous experi-
mental manipulation, thus truly maintaining the steady state. 
In addition, we examined whole populations, rather than a 
small proportion of transferred cells that require extrapola-
tion, to make conclusions about what might have occurred in 
most members of a given population. Though our data are 
consistent with the possibility that nonlymphoid organ DCs 
may arise from monocytes, and indeed we used Ly-6C  hi   
monocytes as a reference population throughout this study, 
our approach cannot prove an origin from monocytes for any 
population. However, because EGFP  +   cells cannot be pre-
cursors for EGFP        cells in these mice, the strength of the 
model lies in its power to reveal which relationships between 
populations cannot be true. 
  Based on the fact that nonlymphoid organ DCs are fre-
quently EGFP  +   in LysM-Cre   ×   Rosa26-stop  fl  ox  EGFP mice 
and lymph nodes DCs are not, we conclude that nonlymphoid 
organ DCs cannot account for the origin of most steady-state 
lymph node DCs, with the exception of discrete populations 
of skin DCs, such as langerin  +   DCs, in skin-draining lymph 
nodes. Because lung and airway DCs are well characterized 
and possess durable markers such as CD103 that independently 
enable tracking in the steady state, this conclusion is particu-
larly clear and striking when lung-draining lymph nodes are 
examined (  5, 40, 47  ). In the small intestine, little information 
is available as to which LP population best migrates into lym-
phatics. We found one population of LP DCs with a very low 
frequency of EGFP (  Fig. 2  , LP1), such that if they migrated 
substantially to lymph nodes in the steady state they would go 
undetected by our method. However, the CD8      +   phenotype 
of these cells is more consistent with the possibility that they 
are contaminants from Peyer  ’  s patches rather than part of the 
LP proper. The major CD11c  +  CD11b  +  MHC II  +   cell we 
identifi  ed in the LP expressed a high frequency of EGFP, but 
little is known about how effi   ciently these cells migrate into 
lymphatics. DCs at the epithelial interface migrate to lymph 
nodes after capturing luminal intestinal antigens (  52  ). The 
CD11b  hi   population that was recovered in both the terminal 
villi and LP preparations is likely to correspond to this DC, 
given that it copurifi  ed to some extent with the epithelium. 
These DCs had an overall lower frequency of EGFP ex-
pression than blood monocytes, suggesting against previous 
conclusions (  25  ) that they are not completely derived from 
monocytes. However, a low level of contamination from Pey-
er  ’  s patch DCs might also, as an artifact, reduce the frequency 
of EGFP  +   cells in this population. In any case, though lower in 2848 ANATOMIC ORIGIN OF LYMPH NODE DENDRITIC CELLS   | Jakubzick et al. 
  Spleen and lung cell suspensions were initially processed similarly to 
lymph nodes. However these tissues required an additional step of erythro-
cyte lysis after the fi  rst fi  ltration. Spleen and lung cells were resuspended for 
1 min in 1 ml of 1  ×   lysing buff  er (BD), followed by the addition of 10 ml of 
0.3 mM EDTA/0.06% BSA/HBSS. Cells were then centrifuged at 1,200 rpm 
for 5 min, fi  ltered, washed, collected, and stained for fl  ow cytometry. 
  To obtain single-cell suspensions of BAL fl  uid, immediately after death, 
the trachea of a mouse was exposed and the mouse was positioned upright by 
inserting one side of a blunt forceps behind the trachea. An 18-gauge needle 
attached to a 3-ml syringe was inserted through the largest upper-cartilage 
ring, and the forceps was gently clamped down on the inserted needle. The 
airways were fl  ushed four times with 1 ml of 0.5 mM EDTA/HBSS. Col-
lected cells were resuspended in FACS blocking solution (HBSS containing 
0.1 mM EDTA, 0.03% BSA [wt/vol], and 0.01% of each rabbit and human 
serum [vol/vol]) and stained for 30 min with conjugated antibodies. 
  To isolate LP DCs, part of the small bowel that included the jejunum 
and ileum was excised by separation from the mesentery. The remaining 
pieces of mesentery containing fat tissue were removed, and intestines were 
opened with scissors along the intestinal length and repeatedly washed from 
intestinal content. Next, intestinal tissues were incubated in the presence of 
1 mM DTT (Sigma-Aldrich) at 37  °  C for 20 min and PBS with 1.3 mM 
EDTA at 37  °  C for 1 h on a shaker. The supernatants that contained a sus-
pension of intestinal epithelial cells, intraepithelial lymphocytes, and a signif-
icant fraction of villi DCs were collected, washed and fi  ltered. The remaining 
pieces of intestinal tissue were subjected to further processing. To enrich the 
LP DC fraction, the muscularis layer of the gut was separated from the rest 
with the use of a dissection microscope (model SZ51; Olympus) and dis-
carded, whereas the remaining tissue that contained the villi and underlying 
submucosa (further referred to as the LP) was subjected to tissue digestion 
with 0.2 mg/ml of type IV collagenase (Sigma-Aldrich) at 37  °  C for 1 h. 
These tissues were homogenized, fi  ltered, and washed. Obtained cells sus-
pensions were stained and analyzed by fl  ow cytometry. 
  Epidermal and dermal cell suspensions were acquired by splitting cut 
ears into two pieces. Both pieces were fl  oated in RPMI 1640 medium con-
taining 1.25 mg/ml of Dispase (BD), with the dermis side down overnight 
at 4  °  C. The next day, the epidermis and dermis were separated, placed in 
1 ml of RPMI 1640 medium containing 1.75mg/ml Liberase III (Roche), cut 
into small pieces, and incubated at 37  °  C for 25 min. After 25 min of incuba-
tion, 100   μ  l of 100 mM EDTA was added for an additional 5 min of incubation. 
Cells were pressed through a 70-  μ  m nylon fi  lter, washed, collected, and 
stained for FACS. 
  Flow cytometry analysis.     The following mAbs from BD (except where 
another vendor is noted) were used for staining: biotinylated mAbs to CD3, 
B220, Ter119, and I-Ab; PE-conjugated mAbs to CD103 (eBioscience), 
CD8, B220, I-Ab, or CD115 (eBioscience); PerCP-Cy5.5  –  conjugated 
mAbs to Gr-1 (recognizes Ly-6C and Ly-6G) and CD11b; and allophyco-
cyanin (APC)-conjugated mAbs to CD11c and pan-NK (eBioscience). 
Biotinylated mAbs were detected with streptavidin-conjugated APC 
(Invitrogen). Conjugated isotype-matched control mAbs were obtained 
from eBiosciences or BD. 
  To distinguish MDPs from monocytes in bone marrow (  37  ), we stained 
for two combinations of lineage markers. Lineage stain 1 used a combination 
of mAbs to CD3, B220, Ter119, I-Ab, CD11c, and pan-NK (detected in 
the APC channel). Cells that were negative for these markers were evaluated 
with lineage stain 2, composed of PerCP-conjugated anti  –  Gr-1 and CD11b 
mAbs. CD115  +   bone marrow cells positive for lineage stain 2 were mono-
cytes, and those negative for both lineage stains were considered MDPs 
(CD115  +   Lin       ) (  37  ). 
  Intracellular staining for langerin was performed after extracellular stain-
ing was done. Cells were fi  xed and permeabilized with Cytofi  x/Cytoperm 
solution (BD) for 20 min at 4  °  C. Then, cells were washed in 1  ×   Perm/Wash 
buff  er (BD). Control goat IgG (R  &  D Systems) or goat anti  –  mouse/rat/
human langerin antibody (Santa Cruz Biotechnology, Inc.) was diluted in 1  ×   
Perm/Wash buff  er at a 1:400 dilution and incubated with permeabilized 
lymph node cells are not considered by most to be classical 
DCs, and they share this phenotype with Ly-6C  lo   mono-
cytes (  33, 57  ), making it tempting to consider all such cells 
as putative monocytes (  37  ). Cells with this phenotype were 
abundant in steady-state lymph nodes, were EGFP  +   like up-
stream tissue counterparts, and may refl  ect an important DC 
type with the capacity to directly present antigen or transfer 
it to other DCs. Particle-bearing, phagocytic monocyte-
derived DCs that emigrate from skin to lymph nodes also 
express low levels of CD11c and very high levels of CD11b 
(  20  ). Yet, little consideration has been given to the possibility 
that these cells have an important role in steady-state lymph 
nodes or, ultimately, in antigen presentation, in part because 
of the evidence that CD11c  hi   cells are required for immune 
priming, even when CD11c  int   cells are not deleted in CD11c-
DTR mice (  58  ). 
  Because we cannot link lymph node DCs substantially to 
upstream tissue DCs, more credence may be given to the 
possibility that lymph node DCs mainly enter lymph nodes 
during the steady state through high endothelial venules. This 
notion still requires direct experimental support. Another in-
teresting possibility to be investigated in future work is that 
the upstream tissue feeds the lymph node with DCs that enter 
through lymphatics, but that these cells circulate in lymph in 
an unexpected form, other than as descendents of tissue-resi-
dent DCs. The recent evidence that hematopoietic progeni-
tor cells are found in lymph raises the possibility that they 
might seed the lymph node, although these progenitors were 
not retained in lymph nodes themselves and were argued to 
play a more important role in generating tissue DCs during 
infl  ammation rather than lymph node DCs in the steady state 
(  59  ). As our fi  ndings challenge long-held views about the 
role of steady-state traffi   cking DCs in comprising lymph node 
populations of DCs, the present work highlights the need to 
investigate in more detail how lymph nodes are populated by 
DCs in the steady state, and the relationship between lymph-
migrating and nonmigratory DCs in presenting antigen un-
der homeostatic conditions. 
  MATERIALS AND METHODS 
  Mice.     LysM-Cre mice (  29  ) were crossed to a reporter strain in which the 
Rosa26 promoter is upstream of a fl  oxed stop cassette and the EGFP gene 
(  30  ). This cross was provided to us by T. Graf (Centre for Genomic Regu-
lation, Barcelona, Spain) (  31  ), and we subsequently backcrossed the mice 
12 generations on the C57BL/6 background before these experiments. 
Wild-type C57BL/6 and control mice in which EGFP is knocked into the 
Rosa26 locus for constitutive expression without the need for deletion of a 
fl  oxed stop cassette (  35  ) were purchased from the Jackson Laboratory. Mice 
were housed in a specific pathogen-free environment at Mount Sinai 
School of Medicine and were used in accordance with protocols approved 
by the Institutional Animal Care and Utilization Committee. 
  Cell suspension of spleen, lymph nodes, and nonlymphoid organ 
DCs.     Skin-draining lymph nodes (brachial, axillary, and inguinal), lung-
draining lymph node (mediastinal), and mesenteric lymph node were ex-
cised, teased with needles and digested in collagenase D (Roche) for 
30 min at 37  °  C. After digestion, 100   μ  l of 100 mM EDTA was added for 
5 min. Cells were then lightly pressed through a 70-  μ  m nylon fi  lter, washed, 
collected, and stained for fl  ow cytometry. JEM VOL. 205, November 24, 2008 
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Perm/Wash buff  er at a 1:300 concentration and incubated with permeabi-
lized cells for 20 min at 4  °  C. Finally, cells were washed once in 1  ×   Perm/
Wash buff  er, followed by a wash in PBS. Cells were resuspended in PBS and 
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  Fluorescent labeling of DC migration in the skin.     To analyze migrat-
ing skin DCs, TRITC (Sigma-Aldrich) was prepared as a stock solution at 
100 mg/ml in DMSO and further diluted to a fi  nal concentration of 10 mg/ml 
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  Online supplemental material.     Fig. S1 analyzes EGFP intensity to de-
termine if EGFP  +   DCs might proliferate and dilute EGFP in the process. 
Online supplemental material is available at http://www.jem.org/cgi/
content/full/jem.20081430/DC1. 
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